WOOJUNG BIO Announces Head Office Building Name Change No Impact on Shareholder Value as Only Building Name Changes
WOOJUNG BIO announced on July 8, 2026 via board resolution that the building name of its head office location will change from WOOJUNG BIO New Drug Cluster to Kolmar Bio Cluster.
The actual address 593-8 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do remains unchanged; this is purely an administrative name change within the same building.
This change does not involve any physical relocation or capital alteration, therefore it has zero impact on the existing share count or financial structure.
[AI Summary]The head office building name change is a mere administrative matter with no connection to stock dilution or capital redeployment. From an investor perspective, there is no substantive change, making this a neutral event.